Securities code: 002294 securities abbreviation: Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) No.: 2022-014 Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Announcement on retirement of senior managers
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) (hereinafter referred to as “the company”) recently received a written resignation report submitted by Ms. Zhu MEIXIA, deputy general manager of the company. Ms. Zhu MEIXIA applied to resign as deputy general manager of the company because she reached the retirement age. After the resignation takes effect, he will no longer hold any position in the company.
According to the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, the articles of association and other provisions, Ms. Zhu MEIXIA’s resignation report takes effect when it is delivered to the board of directors. Ms. Zhu MEIXIA’s resignation will not affect the normal operation of relevant work of the company.
As of the disclosure date of this announcement, Ms. Zhu MEIXIA has no commitments that should be fulfilled but not fulfilled. It indirectly holds 300000 shares of the company through the employee stock ownership plan. After leaving office, Ms. Zhu MEIXIA will continue to abide by relevant laws and regulations such as the company law of the people’s Republic of China, the guidelines for the management of shares held by directors, supervisors and senior managers of listed companies and their changes, and the guidelines for self-discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board Share management shall be carried out in accordance with relevant provisions such as normative documents and management measures for employee stock ownership plans. The company will handle relevant share locking matters at the clearing company in accordance with the regulations.
The company expresses heartfelt thanks to Ms. Zhu MEIXIA for her contributions during her tenure!
It is hereby announced
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Board of directors February 7, 2002
